Back
G1 Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
GTHX
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.15
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.G1 Therapeutics Price Quote
$7.15
G1 Therapeutics Key Stats
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Day range:
$7.15 - $7.15
52-week range:
$1.08 - $7.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.40
P/B ratio:
15.34%
Volume:
0
Avg. volume:
3.1M
1-year change:
379.87%
Market cap:
$377.2M
Revenue:
$82.5M
EPS:
$-0.86
How Much Does G1 Therapeutics Make?
-
How Much Are G1 Therapeutics's Sales Annually?
GTHX Revenues are $82.5M -
How Much Profit Does G1 Therapeutics's Make A Year?
GTHX net income is -$48M
Is G1 Therapeutics Growing As A Company?
-
What Is G1 Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.61% -
What Is G1 Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
G1 Therapeutics Stock Price Performance
-
Did G1 Therapeutics Stock Go Up Last Month?
G1 Therapeutics share price went up by 0.56% last month -
Did GTHX's Share Price Rise Over The Last Year?
GTHX share price rose by 379.87% over the past 1 year
What Is G1 Therapeutics 52-Week High & Low?
-
What Is G1 Therapeutics’s 52-Week High Share Price?
G1 Therapeutics has traded as high as $7.19 over the past 52 weeks -
What Is G1 Therapeutics’s 52-Week Low Share Price?
G1 Therapeutics has traded as low as $1.08 over the past 52 weeks
G1 Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy G1 Therapeutics?
-
How Much Debt Does G1 Therapeutics Have?
Total long term debt quarterly is $44.3M -
How Much Cash Does G1 Therapeutics Have?
Cash and short term investments quarterly total is $60.7M -
What Is G1 Therapeutics’s Book Value Per Share?
Book value per share is 0.47
Is G1 Therapeutics Cash Flow Positive?
-
What Is GTHX Cash Flow From Operations?
Cash flow from operations (TTM) is -$37.5M -
What Is G1 Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8.4M -
What Is G1 Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $5.1M
G1 Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
GTHX return on invested capital is -52.13% -
What Is G1 Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -37.11% -
What Is GTHX Return On Equity?
ROE is a measure of profitability and is -118.89%
G1 Therapeutics Earnings Date & Stock Price
-
What Is G1 Therapeutics's Stock Price Today?
A single share of GTHX can be purchased today for 7.15 -
What Is G1 Therapeutics’s Stock Symbol?
G1 Therapeutics trades on the nasdaq under the ticker symbol: GTHX -
When Is G1 Therapeutics’s Next Earnings Date?
The next quarterly earnings date for G1 Therapeutics is scheduled on November 1, 2024 -
When Is GTHX's next ex-dividend date?
G1 Therapeutics's next ex-dividend date is May 20, 2020 -
How To Buy G1 Therapeutics Stock?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
G1 Therapeutics Competitors
-
Who Are G1 Therapeutics's Competitors?
Below is a list of companies who compete with G1 Therapeutics or are related in some way:
G1 Therapeutics Dividend Yield
-
What Is GTHX Dividend Yield?
G1 Therapeutics’s dividend yield currently is 0% -
What Is G1 Therapeutics’s Payout Ratio?
G1 Therapeutics’s payout ratio is 0% -
When Did G1 Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 21, 2024 -
What Is G1 Therapeutics’s Dividend Per Share?
G1 Therapeutics pays a dividend of $0.00 per share
G1 Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 38.05% |
Revenue: | -60.97% | 3.24% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 7.15 |
Upside from Last Price: | 0% |